Merck to Acquire Indy Company in $780M Deal

A Hoosier biopharmaceutical contract development and manufacturing organization will soon be under new ownership. Germany-based Merck KGaA has announced plans to acquire Exelead, headquartered in Indianapolis, in a $780 million deal. Merck ... Read More

Lilly Antibody Therapies Paused

The U.S. Department of Health and Human Services has paused the distribution of COVID-19 antibody therapies developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY), as well as one from another pharmaceutical company. The agency cites new data that shows the therapies are unlikely to be effective against the Omicron variant.... Read More

Roche Receives EUA for At-Home COVID Test

The U.S. Food and Drug Administration has granted an Emergency Use Authorization for a COVID-19 At-Home Test developed by Roche Diagnostics. The company says the test will be available across the country beginning in January.... Read More

Pharma Company Lands FDA Approval for Imaging Product

An Australian pharmaceutical company with a major presence in central Indiana has hit a major milestone. Telix Pharmaceuticals Inc., which has its U.S. headquarters in Fishers, has received approval from the U.S. Food and Drug Administration for its lead prostate cancer imaging product.... Read More

Purdue ‘Light Up’ Cancer Technology Earns FDA Approval

After more than a decade of work, Purdue University-based On Target Laboratories Inc. has claimed the “holy grail” of biotech startups; just days ago, the U.S. Food and Drug Administration approved CYTALUX, a surgical innovation for cervical cancer from the lab of Purdue’s Dr. Philip Low, who has launched seven companies and sold Endocyte for […]... Read More

Notre Dame Prof Nears Launch of New Ortho Material

A new material invented by a professor at the University of Notre Dame for spinal implants is likely just months away from being used on the first patients. Implants used for spinal fusion have long been made out of a polymer called PEEK, because it’s “a good material” with excellent mechanical properties, says Notre Dame […]... Read More

Langham Logistics to Open Life Sciences-Focused Facility

The biggest vaccination campaign in history is creating new pressures in logistics, and an Indianapolis-based company is responding by building a distribution facility designed specifically for the shifting demands of the life sciences industry. Langham Logistics says the new distribution center—the company’s first one north of Indianapolis—will also support a recent explosion of life sciences […]... Read More

Inotiv Swings to Full-Year Profit

West Lafayette-based Inotiv Inc. (Nasdaq: NOTV) is reporting fiscal full-year net income of $10.9 million, compared to a loss of $4.7 million the previous year. Chief Executive Officer Robert Leasure says the transformational year reflected the company's success in "expanding existing operations and services, starting up new services, and acquiring strategic assets."... Read More

Low: FDA Approval Could Be Revolutionary for Cancer Surgery

The founder of West Lafayette-based On Target Laboratories Inc. says the recent approval from the U.S. Food and Drug Administration for the company's imaging drug Cytalux brings "a whole rainbow of emotions." Cytalux uses fluorescent technology to help surgeons spot ovarian cancer tumors. ... Read More

Lilly to Collaborate with Chinese Company

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has inked a research collaboration and licensing agreement with Regor Therapeutics Group, which is co-located in China and Boston. Lilly says as part of the deal, the companies will work together to discover, develop and commercialize novel therapies for metabolic disorders.... Read More

EUA Expanded for Lilly COVID Combo Therapy

The U.S. Food and Drug Administration has expanded the Emergency Use Authorization for a combination therapy developed by Indianapolis-based Eli Lilly and Co. (NYSE: LLY) to treat patients with COVID-19. Lilly says bamlanivimab and etesevimab can now be used to treat certain high-risk pediatric patients from birth to 12 years old.... Read More

Plastics Company Expands Elkhart Facility

Wisconsin-based Placon is celebrating the opening of its expanded medical facility in Elkhart. The Elkhart Truth reports the plastic packaging manufacturer has invested $11 million to construct the 42,000-square-foot addition and create up to 25 jobs.... Read More

Paragon Builds $16M 3D Printing Center for Implants

The global market for 3D printed medical devices is expected to grow by $2.3 billion in the next four years, says a global technology research company. While 3D printed medical devices encompass a variety of devices, it was orthopedic and spinal 3D printing that took the largest slice of the revenue “pie” in 2020. With […]... Read More

Notre Dame Developing Device to Diagnose Heart Attack in Minutes

Despite the urgency of treating a heart attack, the process of diagnosing one can seem painstakingly slow. In most cases, when a patient comes to the emergency room with symptoms of a heart attack, doctors will order a troponin test. However, the test measures a marker that can take up to six hours after a […]... Read More

World’s First Smart Knee Opens Door to More Smart Joints

An Indiana-based orthopedic powerhouse is launching the world’s first “smart” implant. Zimmer Biomet Holdings Inc.’s new Persona IQ Knee Implant is embedded with tiny sensors that—inside the patient’s knee—measure range of motion, step count, walking speed and other gait metrics. The data is delivered wirelessly to the cloud, so the patient and clinician have newfound […]... Read More

Pitch Win Boosts Freezer ‘Pod’ for Vaccines

If the brilliant engineering minds at Rolls-Royce in Indianapolis know how to cool fire-hot jet engines, perhaps they could also help surmount one of the biggest challenges in the global distribution of Covid-19 vaccines: keeping them cold. The concept has crystalized into an Indiana-made freezer “pod” called ArcticRx, which its creators say can keep contents […]... Read More

Genezen CEO: Location Creates Opportunity

The chief executive officer of Fishers-based Genezen says the Hamilton County city's central location provides an ideal environment for growth. The cell and gene therapy contract development and manufacturing organization today announced plans to... Read More

Genezen Continues Life Sciences Growth in Fishers

The life sciences sector in Hamilton County continues to grow. Fishers-based cell and gene therapy contract development and manufacturing organization Genezen has announced plans to invest $40 million to expand its Fishers facility and create up to 62 jobs by the end of 2023. ... Read More